Xyzal and Keratitis - a phase IV clinical study of FDA data

Summary:

Keratitis is reported as a side effect among people who take Xyzal (levocetirizine dihydrochloride), especially for people who are female, 50-59 old, also take Lyrica, and have Osteoporosis.

The phase IV clinical study analyzes which people have Keratitis when taking Xyzal. It is created by eHealthMe based on reports of 20,548 people who have side effects when taking Xyzal from the FDA, and is updated regularly.

What is Xyzal?

Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.

What is Keratitis?

Keratitis (eye's cornea, the front part of the eye, becomes inflamed) is found to be associated with 412 drugs and 839 conditions by eHealthMe. Check the latest studies of Keratitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

20,548 people reported to have side effects when taking Xyzal.
Among them, 16 people (0.08%) have Keratitis.

Among these 16 people:

What is the gender of people who have Keratitis when taking Xyzal? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Keratitis when taking Xyzal? *

What are other drugs people take besides Xyzal? *

What are other side effects people have besides Keratitis? *

Diarrhea: 13 people, 81.25%
Visual Impairment: 10 people, 62.50%
Nausea (feeling of having an urge to vomit): 10 people, 62.50%
Dizziness: 10 people, 62.50%
Eye Discharge: 10 people, 62.50%
Eye Disorder: 10 people, 62.50%
Joint Pain: 10 people, 62.50%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 62.50%
Fatigue (feeling of tiredness): 10 people, 62.50%
Nausea And Vomiting: 10 people, 62.50%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 37.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 12.50%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 12.50%
Urine Output - Decreased: 1 person, 6.25%
Dyspnea (difficult or laboured breathing): 1 person, 6.25%
Asthma: 1 person, 6.25%
Athlete's Foot (a fungal infection affecting the skin between the toes): 1 person, 6.25%
Back Pain: 1 person, 6.25%
Canker Sores (painful, open sore in the mouth): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Xyzal and have Keratitis?

- Check whether Keratitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xyzal:

Xyzal (21,479 reports)

Keratitis treatments and more:

Keratitis (4,120 reports)

How severe was Keratitis and when was it recovered:

Keratitis in Xyzal

Expand to all the drugs that have ingredients of levocetirizine dihydrochloride:

Keratitis and drugs with ingredients of levocetirizine dihydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xyzal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Keratitis:

Keratitis (412 drugs)

Browse all the conditions that are associated with Keratitis:

Keratitis (839 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levocetirizine dihydrochloride (the active ingredients of Xyzal) and Xyzal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.